Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2020.0851
Abstract: Importance Use of biologic agents in generalized myasthenia gravis is generally limited to therapy-refractory cases; benefit in new-onset disease is unknown. Objective To assess rituximab in refractory and new-onset generalized myasthenia gravis and rituximab vs… read more here.
Keywords: generalized myasthenia; new onset; treatment; myasthenia gravis ... See more keywords
Epigenome-wide DNA methylation analysis of myasthenia gravis.
Sign Up to like & getrecommendations! Published in 2023 at "FEBS open bio"
DOI: 10.1002/2211-5463.13656
Abstract: Myasthenia gravis (MG) is a common neuromuscular junction (NMJ) disorder and autoimmune disease mediated by several antibodies. Several studies have shown that genetic factors play an important role in MG pathogenesis. To gain insight into… read more here.
Keywords: methylation; methylation analysis; dna methylation; wide dna ... See more keywords
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51492
Abstract: To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment. read more here.
Keywords: drug refractory; gravis clinical; refractory myasthenia; myasthenia gravis ... See more keywords
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51706
Abstract: This study aimed to explore the relationship between systemic inflammation markers and clinical activity, respiratory failure, and prognosis in patients with myasthenia gravis (MG). read more here.
Keywords: patients myasthenia; inflammation markers; myasthenia gravis; respiratory failure ... See more keywords
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51746
Abstract: Use of tacrolimus in mild to moderate myasthenia gravis (MG) is generally limited to glucocorticoid‐refractory cases; the advantage of mono‐tacrolimus over mono‐glucocorticoids is unknown. read more here.
Keywords: tacrolimus; myasthenia gravis; tacrolimus mono; mono tacrolimus ... See more keywords
Mortality of myasthenia gravis: a national population-based study in China.
Sign Up to like & getrecommendations! Published in 2023 at "Annals of clinical and translational neurology"
DOI: 10.1002/acn3.51792
Abstract: OBJECTIVE As a potentially life-threatening condition, myasthenia gravis (MG) has limited epidemiological studies on mortality. We aim to provide demographic distribution, geographical variation, and temporal trend of MG-related mortality in China. METHODS The national population-based… read more here.
Keywords: age; mortality; rate; myasthenia gravis ... See more keywords
miR‐30e‐5p as predictor of generalization in ocular myasthenia gravis
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.692
Abstract: To determine a predictive factor for the risk of conversion from ocular myasthenia gravis (OMG) to generalized MG (GMG) in a prospective study. read more here.
Keywords: ocular myasthenia; mir 30e; myasthenia gravis; 30e predictor ... See more keywords
Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26507
Abstract: Myasthenia gravis (MG) is an autoimmune disease in which pathogenic immunoglobulin G antibodies bind to acetylcholine receptors (or to functionally related molecules at the neuromuscular junction). B cell expression of the inhibitory immunoglobulin G receptor, Fc‐gamma receptor… read more here.
Keywords: receptor iib; cell expression; expression; expression inhibitory ... See more keywords
Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26590
Abstract: Myasthenia gravis (MG) is a neuromuscular disease mediated by antibodies against the acetylcholine receptor (AChR). The thymus plays a primary role in AChR‐MG and is characterized by a type I interferon (IFN) signature linked to… read more here.
Keywords: ifn signature; myasthenia gravis; central role; myasthenia ... See more keywords
LncRNA GAS5 positively regulates IL‐10 expression in patients with generalized myasthenia gravis
Sign Up to like & getrecommendations! Published in 2021 at "Brain and Behavior"
DOI: 10.1002/brb3.2457
Abstract: LncRNA growth arrest‐specific transcript 5 (GAS5) has been proven to be involved in autoimmune diseases. Rheumatoid arthritis is a type of autoimmune disease that may affect myasthenia gravis (MG) patients. However, its direct role in… read more here.
Keywords: myasthenia gravis; lncrna gas5; gas5; positively regulates ... See more keywords
COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2
Sign Up to like & getrecommendations! Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2789
Abstract: This review highlights the potential mechanisms of neuromuscular manifestation of COVID‐19, especially myasthenia gravis (MG). read more here.
Keywords: covid myasthenia; review; review neurological; gravis review ... See more keywords